GB0322848D0 - Tetracycline controlled release pharmaceutical dosage form - Google Patents

Tetracycline controlled release pharmaceutical dosage form

Info

Publication number: GB0322848D0
Authority: GB; United Kingdom
Prior art keywords: dosage form; controlled release; pharmaceutical dosage; release pharmaceutical; tetracycline controlled
Prior art date: 2003-09-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0322848.3A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Accord UK Ltd

Original Assignee

Alpharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-30

Filing date

2003-09-30

Publication date

2003-10-29

2003-09-30 Application filed by Alpharma Ltd filed Critical Alpharma Ltd

2003-09-30 Priority to GBGB0322848.3A priority Critical patent/GB0322848D0/en

2003-10-29 Publication of GB0322848D0 publication Critical patent/GB0322848D0/en

2004-09-30 Priority to GB0421759A priority patent/GB2406517B/en

2004-09-30 Priority to GB0524368A priority patent/GB2420708A/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0322848.3A 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form Ceased GB0322848D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GBGB0322848.3A GB0322848D0 (en)	2003-09-30	2003-09-30	Tetracycline controlled release pharmaceutical dosage form
GB0421759A GB2406517B (en)	2003-09-30	2004-09-30	Minocycline controlled release pharmaceutical composition
GB0524368A GB2420708A (en)	2003-09-30	2004-09-30	Tetracycline controlled release pharmaceutical composition

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0322848.3A GB0322848D0 (en)	2003-09-30	2003-09-30	Tetracycline controlled release pharmaceutical dosage form

Publications (1)

Publication Number	Publication Date
GB0322848D0 true GB0322848D0 (en)	2003-10-29

Family

ID=29287107

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
GBGB0322848.3A Ceased GB0322848D0 (en)	2003-09-30	2003-09-30	Tetracycline controlled release pharmaceutical dosage form
GB0421759A Expired - Fee Related GB2406517B (en)	2003-09-30	2004-09-30	Minocycline controlled release pharmaceutical composition
GB0524368A Withdrawn GB2420708A (en)	2003-09-30	2004-09-30	Tetracycline controlled release pharmaceutical composition

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
GB0421759A Expired - Fee Related GB2406517B (en)	2003-09-30	2004-09-30	Minocycline controlled release pharmaceutical composition
GB0524368A Withdrawn GB2420708A (en)	2003-09-30	2004-09-30	Tetracycline controlled release pharmaceutical composition

Country Status (1)

Country	Link
GB (3)	GB0322848D0 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8722650B1 (en)	2005-06-24	2014-05-13	Medicis Pharmaceutical Corporation	Extended-release minocycline dosage forms
US20080242642A1 (en)	2007-04-02	2008-10-02	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en)	2007-04-02	2012-08-28	Medicis Pharmaceutical Corporation	Minocycline oral dosage forms for the treatment of acne
US9561241B1 (en)	2011-06-28	2017-02-07	Medicis Pharmaceutical Corporation	Gastroretentive dosage forms for minocycline
WO2016162754A1 (en)	2015-04-07	2016-10-13	Dr. Reddy's Laboratories Ltd.	Pharmaceutical compositions for minocycline

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3623997A (en) *	1966-06-06	1971-11-30	Ncr Co	Wall-sealing treatment for minute capsules and minute capsules having walls of sealed polymeric material
JPS5231981A (en) *	1975-08-18	1977-03-10	Takeda Chem Ind Ltd	Microcapsule preparation method
ATE283038T1 (en) *	1995-07-21	2004-12-15	Daiichi Seiyaku Co	METHOD FOR PRODUCING A GRANULAR PREPARATION
ITMI991316A1 (en) *	1999-06-14	2000-12-14	Cip Ninety Two 92 S A	ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF MESALAZINE
WO2003004009A1 (en) *	2001-07-02	2003-01-16	Geneva Pharmaceuticals, Inc.	Pharmaceutical composition

2003
- 2003-09-30 GB GBGB0322848.3A patent/GB0322848D0/en not_active Ceased
2004
- 2004-09-30 GB GB0421759A patent/GB2406517B/en not_active Expired - Fee Related
- 2004-09-30 GB GB0524368A patent/GB2420708A/en not_active Withdrawn

Also Published As

Publication number	Publication date
GB2420708A (en)	2006-06-07
GB2406517A (en)	2005-04-06
GB0421759D0 (en)	2004-11-03
GB2406517B (en)	2006-07-12
GB0524368D0 (en)	2006-01-04

Publication	Publication Date	Title
IL177566A0 (en)	2006-12-10	Pharmaceutical formulations
PL373914A1 (en)	2005-09-19	Immediate release dosage forms containing solid drug dispersions
IL180706A0 (en)	2007-06-03	Pharmaceutical dosage forms including rasagiline
GB0302671D0 (en)	2003-03-12	Pharmaceutical formulations
TWI319318B (en)	2010-01-11	Modified release pharmaceutical formulation
EP1553925A4 (en)	2012-09-05	Modified release oral dosage form
IL172824A0 (en)	2006-06-11	Pharmaceutical formulations
PL376840A1 (en)	2006-01-09	Prolonged release pharmaceutical composition
IL165069A0 (en)	2005-12-18	Immediate release pharmaceutical formulation
GB0316206D0 (en)	2003-08-13	Pharmaceutical formulation
IL163887A0 (en)	2005-12-18	Controlled release dosage forms
GB0302672D0 (en)	2003-03-12	Pharmaceutical formulations
EP1753405A4 (en)	2008-09-17	Controlled release pharmaceutical formulation
GB0423800D0 (en)	2004-12-01	New pharmaceutical formulations
GB0416397D0 (en)	2004-08-25	Pharmaceutical formulations
PL1753398T3 (en)	2019-04-30	Controlled release matrix pharmaceutical dosage formulation
AU2003261067A8 (en)	2004-04-30	Modified release ketoprofen dosage form
GB0316341D0 (en)	2003-08-13	Pharmaceutical formulations
HK1072194A1 (en)	2005-08-19	Oral dosage form for controlled drug release
GB0322848D0 (en)	2003-10-29	Tetracycline controlled release pharmaceutical dosage form
HK1094676A1 (en)	2007-04-04	Solid pharmaceutical preparation form
ZA200603126B (en)	2007-02-28	Pharmaceutical compositions for therapeutic use
GB0310881D0 (en)	2003-06-18	Pharmaceutical formulation
GB0316335D0 (en)	2003-08-13	Pharmaceutical formulations
GB0315019D0 (en)	2003-07-30	Dosage form

Legal Events

Date	Code	Title	Description
2004-11-03	AT	Applications terminated before publication under section 16(1)